FDA Adverse Event Malfunction Summary report: N

SPRINT QUATTRO SECURE S

MDR report key: 1926321 · Received December 14, 2010

Report

Report Number
2649622-2010-14282
Event Type
Malfunction
Date Received
December 14, 2010
Date of Event
October 12, 2010
Manufacturer
MEDTRONIC PUERTO RICO, INC.
Product Code
LWS
PMA / PMN Number
P920015/S039
Removal / Correction Number
ASKU
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED OUTSIDE THE US. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. EVALUATION SUMMARY: (B)(4) THE FULL LEAD WAS RETURNED, ANALYZED AND NO ANOMALIES WERE FOUND. IT WAS NOTED THAT THE INNER TUBING WAS KINKED/BUCKLED, THERE WAS BLOOD IN/ON THE HELIX/LOBE MECHANISM AND THE LEAD APPEARED DAMAGED AT IMPLANT.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED OUTSIDE THE US. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. ANALYSIS OF THE DEVICE IS IN PROCESS; THE RESULTS WILL BE FORWARDED WHEN AVAILABLE.

Description of Event or Problem · 1

ASKU

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING IMPLANT ATTEMPT, THE VENTRICULAR PACE/SENSE IMPEDANCE WAS MEASURED >2000 OHMS WITH THE ANALYZER OF THE PROGRAMMER. IT WAS ALSO REPORTED THAT WHEN CONNECTED TO THE DEVICE, THE IMPEDANCE WAS MEASURED BY THE DEVICE AT >1800 OHMS AND OVERSENSING ARTIFACTS WERE SENSED. THE LEAD WAS NOT USED AND REPLACED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SPRINT QUATTRO SECURE S IMPLANTABLE TACHY LEAD LWS MEDTRONIC PUERTO RICO, INC. 6935 ASKU

Patients

Seq Age Sex Outcome Treatment
1 Other